Stock Market & Financial Investment News

News Breaks February 14, 2013 15:55 EDT PCYC, PCYC Pharmacyclics to host conference call Management announces that the FDA granted breakthrough therapy designation for ibrutinib monotherapy and discusses 2Q13 earnings results on a conference call to be held on February 14 at 4:30 pm. Webcast Link News For PCYC From The Last 14 Days Check below for free stories on PCYC the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 16, 2013 13:37 EDT PCYC Pharmacyclics updates results of two Phase ll Ibrutinib studies Subscribe for More Information June 11, 2013 07:38 EDT PCYC Pharmacyclics shares should be bought, says RBC Capital Subscribe for More Information June 10, 2013 07:40 EDT PCYC Leerink's biotech analyst holds analyst/industry conference call on ASCO Subscribe for More Information June 6, 2013 08:27 EDT PCYC Bernstein's biotech analysts hold an analyst/industry conference call Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.